Skip to content

Respiratory Physiotherapy and Neurorehabilitation in Patients With Post-covid19 Sequelae.

Effectiveness of a Physiotherapy Respiratory and Neurorehabilitation Treatment Protocol in Patients With COVID-19.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05195099
Enrollment
200
Registered
2022-01-18
Start date
2022-02-01
Completion date
2022-06-17
Last updated
2022-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Pandemic

Keywords

coronavirus, physiotherapies techniques, physiotherapies specialty, agnosia for taste, breathing exercises

Brief summary

The objectives are to reduce dyspnoea, increase exertional capacity, increase vital capacity and respiratory muscle strength. vital capacity and respiratory muscle strength. In addition to increasing the sensibility of smell and taste, observing if there is a relationship between the decrease of these senses with the senses with appetite and whether appetite has normalised in post-SARS-CoV-2 patients. It is a randomised and blinded experimental study with a control group where the sample recruited will be 30 patients, with a range of of 30 patients, with an age range of 19-42 years, where they carried out an assessment of spirometry, modified Borg dyspnoea scales and modified Medical Research Council (MMRC), Singapure (MMRC), Singapore Smell and Taste Questionnaire (SSTQ) and weekly smell and taste questionnaire. taste questionnaire.

Interventions

OTHERrespiratory treatment

Respiratory treatment based on aerobic exercise and treatment of the musculature to reduce dyspnoea and increase the capacity for exertion, neurorehabilitative treatment focusing on the sense of smell and taste to on the sense of smell and taste to increase sensitivity in post Covid-19 subjects.

Sponsors

Universidad Católica de Ávila
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 42 Years
Healthy volunteers
No

Inclusion criteria

* age range between 18 and 42 years. * patients with respiratory sequelae post Covid-19. * patients with smell and taste sequelae post Covid-19.

Exclusion criteria

* Under 18 years old. * Over 42 years old. * Patients not diagnosed with Covid-19 (PCR positive).

Design outcomes

Primary

MeasureTime frameDescription
assessment of spirometry.1 yearmodified Borg dyspnoea scales (0, minimum to 10 maximum rated numerical score used to measure dyspnea as reported by the patient during submaximal exercise and is routinely administered during six-minute walk testing)
smell and taste1 weeksmell and taste questionnaire, maximum score (maximum capacity) 40 points. 0 minimum

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026